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Editor by Angel NebredaAbstract Here, we demonstrate a mechanism of TGFb-medi-
ated inhibition of PDGF-induced DNA synthesis in mesangial
cells. TGFb signiﬁcantly inhibited nuclear Akt phosphorylation
without any eﬀect on PDGF-stimulated phosphorylation of
PDGFR at PI 3 kinase binding site (Tyr-751). Remarkably,
TGFb inhibited cyclin D1 and cyclin E expression with concom-
itant decrease in CDK2 activity induced by PDGF. More impor-
tantly, we demonstrate that TGFb signiﬁcantly abolished
Akt-mediated serine-9 phosphorylation of glycogen synthase
kinase 3b (GSK3b), thus prevented its inactivation. Expression
of inactive GSK3bK85R mutant increased cyclin D1 expression
and DNA synthesis similar to PDGF. These results provide the
ﬁrst evidence that TGFb intercepts Akt kinase activity in the
nucleus to block inactivation of GSK3b, leading to attenuation
of PDGF-induced CDK2 activity and DNA synthesis.
 2007 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Platelet-derived growth factor (PDGF) family consists
of four protein chains, which form ﬁve dimers (PDGF-AA,
-AB, -BB, -CC and -DD). PDGF isoforms bind two receptors,
a and b with high aﬃnity [1]. PDGF receptor-a binds PDGF-
A, -B and -C chains, while PDGF receptor-b (PDGFR) inter-
acts with PDGF-B and -D chains, respectively. Although these
two receptors share several biological activities, gene targeting
studies revealed speciﬁc function for the receptors, including
vascular development and embryogenesis [2]. Binding of
PDGF dimer to the receptors induces a conformational
change, which relieves an autoinhibitory eﬀect of the juxta-
membrane domain on the intrinsic tyrosine kinase activity of
the receptor [3]. Both receptors undergo transphosphorylation
to create docking sites for many proteins, which activate signal
transduction pathways including Ras-mitogen-activated pro-*Corresponding author. Address: Department of Medicine, University
of Texas Health Science Center, Mail Code 7882, 7703 Floyd Curl
Drive, San Antonio, TX 78229-3900, United States.
E-mail address: choudhuryg@uthscsa.edu (G. Ghosh Choudhury).
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doi:10.1016/j.febslet.2007.10.014tein kinase, phospholipase Cc and phosphatidylinositol (PI)
3 kinase [3]. We and others have shown an essential role of
PI 3 kinase in PDGF-induced cell proliferation [4,5].
Proliferative glomerular injury is caused by increased hyper-
cellularity of intrinsic glomerular cells including mesangial
cells. A growing body of literature shows the involvement of
PDGF B-chain and PDGFR in proliferation and migration
of mesangial cells [6–8]. Gene disruption studies in mice
showed that PDGF-BB and its PDGFRb are essential for mes-
angial cell development from metanephric mesenchyme [9,10].
Thus PDGFR signaling plays a critical role in glomerular
development and in the pathogenesis of proliferative glomeru-
lonephritis.
Transforming growth factor-b (TGFb) elicits its biological
eﬀects by binding to its type I and type II receptors [11]. Type
II receptor phosphorylates the type I receptor at the GS do-
main, resulting in release of the negative regulatory protein
FKBP12 from GS domain [11]. Subsequently, type I receptor
phosphorylates receptor-speciﬁc Smad 2 and 3. This phosphor-
ylation stimulates dimerization of the R-Smads with the com-
mon partner (co-Smad), Smad 4, which then translocates to
the nucleus, associates with other transcriptional co-activators
or co-repressors to regulate gene transcription [11]. Mesangial
cells contribute to the pathogenesis of ﬁbrotic disorders such as
diabetic nephropathy and glomerulosclerosis [12]. TGFb plays
a prominent role in these diseases by inducing hypertrophy
and expression of extracellular matrix genes. Moreover, we
have reported previously that TGFb inhibited PDGF-induced
mesangial cell proliferation [13]. The signaling mechanism by
which TGFb elicits this eﬀect is not known.
In this report, we show for the ﬁrst time that TGFb inhibits
Akt kinase to attenuate PDGF-induced DNA synthesis. Addi-
tionally, we provide the ﬁrst evidence that TGFb prevents
PDGF-induced phosphorylation of glycogen synthase kinase
3b (GSK3b), which blocks cyclin D1 and cyclin E expression
and CDK2 activity. These results provide a mechanism of
TGFb inhibition of mesangial cell proliferation in response
to PDGF.2. Materials and methods
2.1. Materials
Tissue culture materials were obtained from Gibco-BRL. TGFb1
and PDGF were purchased from R&D Systems. Nuclear extractionblished by Elsevier B.V. All rights reserved.
5260 F. Das et al. / FEBS Letters 581 (2007) 5259–5267kit was from Pierce. The antibodies were purchased from Sigma (tubu-
lin and actin), UBI (anti-phospho-tyrosine and phospho-PDGFR-
tyrosine 751), Zymed (Smad 3), Cell Signaling (phospho-C-terminal
Smad 3, phospho-Akt-serine-473 and threonine 308, Akt, phospho-
GSK3b serine-9 and phospho-pRb serine 807/811), SantaCruz
(GSK3b, lamin B, cyclin D1, cyclin E, CDK2), respectively. The inac-
tive GSK3bK85R mutant plasmid was obtained from Addgene.2.2. Cell culture
Mesangial cells were grown in RPMI 1640 medium with 16% fetal
bovine serum as described [14–16]. The cells were made quiescent in
serum free medium for two days and incubated with 2 ng/ml TGFb fol-
lowed by PDGF as indicated in the ﬁgure legends. Nuclear extracts
were prepared using a kit using the method provided by the vendor
and as described previously [17].A
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Fig. 1. Eﬀect of TGFb on PDGF-induced tyrosine phosphorylation. Quiesce
incubation with PDGF for 5 min. The cell lysates were immunoblotted wi
tyrosine and tubulin (panel B), phospho-C-terminal-Smad 3 and Smad 3 (p
margin. Bottom panels show quantitation of the protein bands. Means ± S.E
panels A and C. In panel B, *P < 0.05 vs. control.2.3. Immunoblotting
Cells were lysed in RIPA buﬀer at 4 C for 30 min and cleared cell
lysates were prepared as described [18]. The cell lysates were immuno-
blotted with antibodies as described previously [18,19].
2.4. Immunoprecipitation and CDK2 immunecomplex kinase assay
The cell lysates were immunoprecipitated with CDK2 antibody. The
immunoprecipitates were incubated with histone H1 in the presence of
c32P-ATP as described [16,19].
2.5. Detection of apoptosis
Apoptosis was measured using a kit, which utilizes Annexin V-FITC
and propidium iodide. The cells were analyzed by ﬂow cytometry in
the University of Texas Health Science Center Core Facility as de-
scribed [14].51
B
250
150
100
75
50
37
PDGF
- -+ +
TGFβ - +- +
1 2 3 4
Tubulin
PDGFR
0
50
100
150
200
PD
G
FR
/T
ub
ul
in
(%
 of
 C
on
tro
l) * *
50
nt mesangial cells were treated with 2 ng/ml TGFb for 15 min prior to
th anti-PDGFR phospho-Tyr-751, anti-PDGFR (panel A), phospho-
anel C) antibodies. Molecular weight markers in kD are shown in the
. of 3–4 independent experiments are shown. *P < 0.001 vs. control in
F. Das et al. / FEBS Letters 581 (2007) 5259–5267 52612.6. DNA synthesis
DNA synthesis was determined as incorporation of 3H-Thymidine
into trichloroacetic acid-insoluble material as described [4,15,16,19].2.7. Immunoﬂuorescence
Immunoﬂuorescence analysis to detect translocation of Akt was per-
formed using phospho-Akt (ser-473) and Akt antibodies essentially as
described [18,20]. The ﬂuorescence was detected using Zeiss-Axio-Im-
ager.A1 microscope with Axiovision 4.5 software.2.8. Transfection
Mesangial cells were transfected with plasmid DNA essentially as
described [16,18,19,21].2.9. Statistics
The signiﬁcance of the data was determined by ANOVA followed by
Student–Newman–Keuls analysis.3. Results
3.1. TGFb inhibits PDGF-induced Akt kinase activity to inhibit
DNA synthesis
TGFb inhibits PDGF-induced mesangial cell proliferation
[13]. We have shown that PI 3 kinase activity is essential for
PDGF-induced DNA synthesis [4]. Activation of PI 3 kinase
depends on its binding to the phosphorylated tyrosine 751 of
the kinase-insert domain of the PDGFR [5]. We tested tyrosine
751 phosphorylation in PDGFR. As shown in Fig. 1A, TGFb
did not have any eﬀect on PDGF-induced PDGFR phosphor-
ylation at tyrosine-751. Thus PI 3 kinase activity may not be
targeted to elicit the inhibitory eﬀect of TGFb on PDGF-in-
duced DNA synthesis. Also, TGFb did not have any eﬀect
on PDGF-induced total tyrosine phosphorylation of cellular
proteins (Fig. 1B). TGFb-stimulated Smad 3 phosphorylation
was unaﬀected by treatment of mesangial cells with PDGF
(Fig. 1C), suggesting that PDGF does not positively regulate
Smad 3 function to promote inhibition of DNA synthesis.
Recently, we have shown that PDGF-stimulated Akt kinase
activity is necessary for DNA synthesis in mesangial cell [16].
As shown in Fig. 2A (and supplementary Fig. S1), we could
not detect signiﬁcant inhibition of PDGF-stimulated Ser-473
and Thr-308 phosphorylation of Akt by TGFb in the cell ly-
sate. In fact, TGFb itself modestly increased Ser-473 phos-
phorylation of Akt (Fig. 2A, lane 3), thus conﬁrming our
previous observation [21]. But, TGFb completely inhibited
PDGF-induced DNA synthesis as determined by 3H-Thymi-
dine incorporation (Fig. 2B). Since loss of 3H-Thymidine
incorporation may result from cell death and since TGFb in-
duces cellular apoptosis, we examined apoptosis of mesangial
cells in response to TGFb. Mesangial cells were analyzed by
ﬂow cytometry for Annexin V binding and propidium iodide
ﬂuorescence. Nearly, 97–99% cells did not bind Annexin V
and propidium iodide, indicating that TGFb did not induce
apoptosis in these cells (Fig. 2C).
Since Akt kinase regulates PDGF-induced DNA synthesis
[16], we critically investigated the eﬀect of TGFb on Akt phos-
phorylation in the nucleus and cytoplasm. Immunoblotting of
cytosolic and nuclear extracts with phospho-Akt antibody
showed signiﬁcant increase in Ser-473 and Thr-308 phosphor-
ylation of Akt in response to PDGF (Fig. 2D, compare lanes 2
with lanes 1). Surprisingly, TGFb signiﬁcantly blocked PDGF-induced phosphorylation of Akt in the nucleus without any ef-
fect in the cytosolic fraction (Fig. 2D, compare lane 4 with lane
2; Supplementary Fig. S2). Similar to cytosolic Akt, PDGF-
induced phosphorylation of Bad, a substrate of Akt, in the
cytosol was unaﬀected by TGFb treatment (Fig. 2E; Supple-
mentary Fig. S3).
A mechanism for reduced phosphorylation of Akt in the nu-
clear fractions may be lack of translocation of Akt in TGFb-
stimulated cells. We tested this hypothesis. Immunoblotting
of Akt in the nuclear extracts showed modest increase in its
abundance in PDGF-treated cells (Fig. 2D, right panel, Akt
blot). TGFb inhibited Akt abundance in the nucleus
(Fig. 2D, compare lane 4 with lane 2). Also, PDGF increased
nuclear translocation of Akt and phospho-Akt as judged by
immunoﬂuorescence analysis (Fig. 2F and G, indicated by ar-
rows). TGFb signiﬁcantly inhibited PDGF-induced Akt trans-
location to the nucleus, resulting in reduced phospho-Akt
abundance in the nucleus (Fig. 2F and G, compare parts d
with parts b). These data for the ﬁrst time indicate that TGFb
targets Akt activation in the nucleus to elicit its inhibitory
eﬀect on PDGF-induced DNA synthesis.3.2. TGFb inhibits cyclin D1 expression in mesangial cells
Mitogens stimulate expression of cyclin D1 in G1 phase to
allow entry of cells into DNA synthesis phase [22]. Therefore,
we tested whether TGFb aﬀects this phenomenon. PDGF in-
creased expression of cyclin D1 in mesangial cells (Fig. 3A).
Preincubation of cells with TGFb inhibited PDGF-induced
expression of cyclin D1 (Fig. 3A). In the late G1 phase, in-
creased cyclin D1 is associated with increased CDK4 activity,
which phosphorylates retinoblastoma protein (pRb) on serine
807/811 residues necessary for cell cycle progression [23].
PDGF increased phosphorylation of pRb at serine 807/811,
which was signiﬁcantly inhibited by TGFb (Fig. 3B). Along
with cyclin D1, cyclin E is also increased, which controls pro-
gression of cells through S-phase [24]. PDGF signiﬁcantly in-
creased the level of cyclin E (Fig. 3C). TGFb prevented the
level of cyclin E in response to PDGF (Fig. 3C). More recently,
we have shown that cyclin E-dependent kinase-2 (CDK2) is
necessary for PDGF-induced DNA synthesis [16,19]. We
investigated the eﬀect of TGFb on CDK2 activity. TGFb sig-
niﬁcantly inhibited PDGF-induced CDK2 activity (Fig. 3D,
compare lane 4 with lane 2). These data indicate that decrease
in DNA synthesis observed by TGFb treatment may be due to
CDK inhibition.3.3. TGFb inhibits PDGF-stimulated phosphorylation of GSK3b
to attenuate DNA synthesis
Increased Akt activity induces phosphorylation of many
substrates, which elicit the biological activity of this kinase
[25]. We considered the involvement of GSK3b, which is phos-
phorylated at serine-9 by growth factor-stimulated Akt kinase,
resulting in its autoinhibition [26,27]. We detected signiﬁcant
amount of GSK3b in the nuclear fraction of mesangial cells
(Fig. 4A, top part). PDGF stimulated phosphorylation of
GSK3b at serine-9 (Fig. 4A, bottom, compare lane 2 with lane
1). Expression of dominant negative Akt kinase signiﬁcantly
inhibited PDGF-induced phosphorylation of GSK3b at ser-
ine-9 (Fig. 4A, bottom, compare lane 4 with lane 2). Remark-
ably, TGFb signiﬁcantly inhibited this phosphorylation in
response to PDGF (Fig. 4B compare lane 4 with lane 2). Since
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Fig. 2. Eﬀect of TGFb on phosphorylation of Akt and DNA synthesis. Mesangial cells were treated with TGFb followed by PDGF as described in
Fig. 1 (panels A, D, E, F and G). In panels B and C, PDGF-treatment was for 20 h. Cell lysates (panel A) and cytosolic and nuclear extracts (panel
D) were immunoblotted with phospho-Akt antibodies (Ser-473 and Thr-308) and Akt antibody. Purity of nuclear and cytosolic extracts was
examined by anti-lamin B and anti-actin immunoblotting (panel D). In panel E, cytosolic extracts were immunoblotted with phospho-Bad and Bad
antibodies, respectively. Quantitation of panels A, D and E are shown in supplementary Fig. S1–S3. In panel B, 3H-thymidine incorporation was
determined as described [4,16]. *P < 0.01 vs. control; **P < 0.01 vs. PDGF-treated. In panel C, apoptosis was measured using an apoptosis detection
kit, which utilizes Annexin V-FITC and propidium iodide ﬂuorescence as described [14]. The numbers in the quadrant indicate percent of apoptotic
cells. Representative of three independent experiments is shown. Molecular weight markers in kD are shown in the margin. (F and G)
Immunoﬂuorescence analyses of total Akt and phospho-Akt (Ser-473). The cells were incubated with anti-Akt (panel F) and anti-phospho-Akt (Ser-
473) (panel G) antibodies respectively, followed by staining with Cy3-tagged donkey anti-rabbit IgG for Ser-473 and anti-mouse IgG for Akt as
described in the Methods [18,20]. Arrows indicate nuclear localization of Akt and phospho-Akt.
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F. Das et al. / FEBS Letters 581 (2007) 5259–5267 5263phosphorylation at serine 9 inactivates GSK3b, these data
indicate that TGFb blocks PDGF-induced inactivation of
GSK3b allowing its activity to persist. Therefore, to examine
directly the role of GSK3b in the cell cycle progression and
DNA synthesis, we tested the eﬀect of kinase inactive
GSK3bK85R mutant. Transfection of GSK3bK85R slightly
but signiﬁcantly increased the level of cyclin D1 (Fig. 4C, com-
pare lane 2 with lane 1 and histogram). However, no additive
eﬀect of GSK3bK85R was observed on PDGF-induced in-
crease in cyclin D1 level (Fig. 4C, lane 4). Next, we examined
the eﬀect of inactive GSK3bK85R on DNA synthesis.
GSK3bK85R signiﬁcantly increased DNA synthesis in mesan-
gial cells although no additive eﬀect was obtained with the
addition of PDGF (Fig. 4D). These results indicate that inac-
tivation of GSK3b may be suﬃcient to induce DNA synthesis
in mesangial cells and that PDGF stimulation of DNA synthe-
sis involves GSK3b inactivation in the nucleus.4. Discussion
These studies represent the ﬁrst demonstration of TGFb
inhibition of PDGF-induced nuclear Akt phosphorylation,
resulting in attenuation of DNA synthesis in mesangial cells.
Our data provide the ﬁrst evidence that TGFb prevents
PDGF-induced inactivating phosphorylation of GSK3b,
which blocks cyclin D1, cyclin E and CDK2 activity, leading
to prevention of DNA synthesis.
We previously reported that PDGF stimulated tyrosine
phosphorylation of multiple proteins in mesangial cells and in-
creased the activity of the lipid modifying enzyme PI 3 kinase
to induce DNA synthesis [15]. PI 3 kinase contains SH2 do-
mains and binds directly to phosphorylated tyrosine 751 of
the PDGFR [3]. Thus, phosphorylation of PDGFR on tyro-
sine 751 is necessary for DNA synthesis [5]. However,
TGFb-mediated inhibition of PDGF-induced DNA synthesis
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Fig. 3. Eﬀect of TGFb on PDGF-induced cyclin and CDK2 activity. (A–C) Mesangial cells were treated with TGFb prior to incubation with PDGF
for 20 h. Cell lysates were immunoblotted with cyclin D1, tubulin, phospho-pRb-serine 807/811, pRb and cyclin E antibodies as indicated in each
panel. (D) CDK2 immunoprecipitates were used in immunecomplex kinase assay with histone H1 as substrate in the presence of c32P-ATP as
described [16,19]. Immunoblotting of the same samples with CDK2 antibody is shown. Molecular weight markers in kD are shown in the margin.
The histograms show quantitation of the protein bands. In panel A, *P < 0.001 vs. control; **P < 0.001 vs. PDGF-stimulated. Panels B–D. *P < 0.05
vs. control; **P < 0.05 vs. PDGF-stimulated.
5264 F. Das et al. / FEBS Letters 581 (2007) 5259–5267was not due to lack of PDGFR phosphorylation at tyrosine
751. These results indicate that TGFb may not target PI 3
kinase to block DNA synthesis.
We have recently shown that PDGF-induced Akt kinase reg-
ulates DNA synthesis in mesangial cells [16]. Our results for
the ﬁrst time show that although TGFb did not have any sig-
niﬁcant eﬀect on PDGF-induced activating phosphorylation of
Akt when examined in the cell lysate, it signiﬁcantly inhibited
PDGF-induced Akt phosphorylation in the nucleus due to
lack of translocation. Since activated Akt kinase present in
the nucleus is necessary for many biological functions [28], thisaction of TGFb may inhibit DNA synthesis in response to
PDGF.
GSK3b is involved in modulating a diverse number of cellu-
lar functions including metabolism, gene expression and cell
proliferation [29]. GSK3b is constitutively active in resting
cells and exists in both cytosolic and nuclear compartment
[29,30]. However, the nuclear GSK3b is more active than the
cytosolic kinase [30]. GSK3b regulates DNA synthesis by con-
trolling transcription factors, which regulates mitogenesis.
GSK3b is typically regulated by inhibition in response to cel-
lular signals, which induce phosphorylation at serine-9 [29].
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on serine-9, resulting in its inactivation [26]. In line with these
results, we demonstrate that in the mesangial cells, PDGF in-
creases phosphorylation of GSK3b serine-9 in the nucleus.
Furthermore, our data for the ﬁrst time show that TGFb
inhibits this phosphorylation, indicating sustained constitutive
activation of GSK3b, which results in inhibition of DNA syn-
thesis. These results are further supported by our observation
that kinase inactive GSK3bK85R increased DNA synthesis in
mesangial cells. Recently, TGFb2 has been shown to attenuate
FGF2-induced corneal endothelial cell proliferation by in-
creased synthesis of PGE2, which renders an inhibitory eﬀect
on Akt [31]. However, the mechanism was not elucidated.
Our results for the ﬁrst time provide a mechanism of TGFb ac-
tion on PDGF-induced DNA synthesis involving Akt-medi-
ated prevention of inactivation of GSK3b.
Activation of cyclin D1-dependent kinase in the early and
late G1 phase is necessary for transition through the restriction
point into DNA synthesis [24]. PDGF stimulated cyclin D1
expression. Level of cyclin D1 is primarily regulated at the le-
vel of gene transcription and proteasomal degradation [32,33].
In fact, inactivation of GSK3b results in catenin-TCF-depen-
dent transcriptional activation of cyclin D1 [33]. On the other
hand, phosphorylation of cyclin D1 by GSK3b promotes its
degradation [32]. We show that TGFb inhibits the inactivating
phosphorylation of GSK3b, thus providing a mechanism for
its sustained activity to inhibit cyclin D1 expression. Indeed,
TGFb inhibited PDGF-induced cyclin D1. Furthermore, inac-
tive mutant of GSK3bK85R signiﬁcantly increased level of cy-
clin D1 and DNA synthesis. These data indicate a role for
TGFb to target GSK3b as a mechanism for inhibition of cyclin
D1 expression in mesangial cells.
Cyclin E also plays important role in S-phase by activating
CDK2, which signiﬁcantly contributes to DNA synthesis
[24]. A recent report showed that GSK3b-mediated phosphor-
ylation of cyclin E at threonine 380 decreases its protein level
[34]. Thus, inactivation of GSK3b by PDGF-induced serine-9
phosphorylation would retain the level of cyclin E to increase
CDK2 activity. Indeed, PDGF increased the level of cyclin E
and CDK2 activity in mesangial cells, suggesting a role for
inactivated GSK3b. Furthermore, TGFb inhibited PDGF-in-
duced inactivation of GSK3b, resulting in attenuation of cyclin
E and CDK2 activity. These results show a mechanism of
TGFb inhibition of PDGF-induced DNA synthesis by target-
ing CDK2 activity.
The role of GSK3b in biology of mesangial cells and other
kidney cells remains to be explored. Our results provide the
ﬁrst evidence that TGFb targets nuclear Akt kinase to modu-
late GSK3b serine-9 phosphorylation for regulating PDGF-in-
duced DNA synthesis. Since increased mesangial cell
proliferation by PDGFR activation is a prominent feature in
inﬂammatory glomerular diseases, activating nuclear GSK3b
may provide an eﬀective therapy for proliferative glomerular
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